Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality

Intensive Care Medicine

Volumn 36, Issue 4, 2010, Pages 621-629

  Mauri, Tommaso ^a,f   Bellani, Giacomo ^a,f   Patroniti, Nicolo' ^a,f   Coppadoro, Andrea ^a,f   Peri, Giuseppe ^b   Cuccovillo, Ivan ^b   Cugno, Massimo ^c   Iapichino, Gaetano ^c,d   Gattinoni, Luciano ^c,e   Pesenti, Antonio ^a,f   Mantovani, Alberto ^b,c  

^a SAN GERARDO HOSPITAL   (Italy)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d SAN PAOLO HOSPITAL   (Italy)

^e FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^f UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Markers; Organ failure; Outcome; Pentraxin 3 (PTX3); Septic shock; Severe sepsis

Indexed keywords

INSULIN; PENTRAXIN 3; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN;

ADULT; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; CORRELATION ANALYSIS; DENDRITIC CELL; DISEASE SEVERITY; ENDOTHELIUM CELL; FEMALE; FIBRINOLYSIS; GLYCEMIC CONTROL; HUMAN; INFLAMMATION; INTENSIVE CARE UNIT; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUTROPHIL; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SEPSIS; SEPTIC SHOCK; STATISTICAL MODEL; THROMBOCYTE COUNT;

ANALYSIS OF VARIANCE; APACHE; BIOLOGICAL MARKERS; BLOOD COAGULATION DISORDERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; FEMALE; HUMANS; INTENSIVE CARE UNITS; INTERLEUKIN-6; LINEAR MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; ROC CURVE; SEPSIS; SERUM AMYLOID P-COMPONENT; SHOCK, SEPTIC; STATISTICS, NONPARAMETRIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77951204731     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-010-1752-5     Document Type: Article

References (40)

1. B Bottazzi C Garlanda A Cotena F Moalli S Jaillon L Deban A Mantovani 2009 The long pentraxin PTX3 as a prototypic humoral pattern recognition receptor: interplay with cellular innate immunity Immunol Rev 227 9 18 10.1111/j.1600-065X.2008.00719.x 1:CAS:528:DC%2BD1MXhsFGls7%2FE 19120471
2. MB Pepys GM Hirschfield 2003 C-reactive protein: a critical update J Clin Invest 111 1805 1812 1:CAS:528:DC%2BD3sXkvV2ktb0%3D 12813013
3. V Vidal Alles B Bottazzi G Peri J Golay M Introna A Mantovani 1994 Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes Blood 84 3483 3493
4. A Doni G Mantovani C Porta J Tuckermann HM Reichardt A Kleiman M Sironi L Rubino F Pasqualini M Nebuloni S Signorini G Peri A Sica P Beck-Peccoz B Bottazzi A Mantovani 2008 Cell-specific regulation of PTX3 by glucocorticoid hormones in hematopoietic and nonhematopoietic cells J Biol Chem 283 29983 29992 10.1074/jbc.M805631200 1:CAS:528:DC%2BD1cXht1ynt7bP 18703503
5. C Garlanda B Bottazzi A Bastone A Mantovani 2005 Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility Annu Rev Immunol 23 337 366 10.1146/annurev.immunol.23.021704.115756 1:CAS:528:DC%2BD2MXktFOjurw%3D 15771574 (Pubitemid 40563173)
6. E Napoleone A di Santo A Bastone G Peri A Mantovani G de Gaetano MB Donati R Lorenzet 2002 Long pentraxin PTX3 upregulates tissue factor expression in human endothelial cells: a novel link between vascular inflammation and clotting activation Arterioscler Thromb Vasc Biol 22 782 787 10.1161/01.ATV.0000012282.39306.64 1:CAS:528:DC%2BD38XjslGmtbg%3D 12006390 (Pubitemid 34517789)
7. E Napoleone A di Santo G Peri A Mantovani G de Gaetano MB Donati R Lorenzet 2004 The long pentraxin PTX3 up-regulates tissue factor in activated monocytes: another link between inflammation and clotting activation J Leukoc Biol 76 203 209 10.1189/jlb.1003528 1:CAS:528:DC%2BD2cXlsVOisLk%3D 15226367 (Pubitemid 38857188)
8. X He B Han X Bai Y Zhang M de Cypel M Mura S Keshavjee M Liu 2010 PTX3 as a potential biomarker of acute lung injury: supporting evidence from animal experimentation Intensive Care Med 36 356 364 10.1007/s00134-009-1720-0 19921147
9. I Cinel SM Opal 2009 Molecular biology of inflammation and sepsis: a primer Crit Care Med 37 291 304 10.1097/CCM.0b013e31819267fb 1:CAS:528:DC%2BD1cXhsFCnu7jE 19050640
10. E Abraham M Singer 2007 Mechanisms of sepsis-induced organ dysfunction Crit Care Med 35 2408 2416 10.1097/01.CCM.0000282072.56245.91 17948334 (Pubitemid 47476242)
11. V Novack M Eisinger A Frenkel M Terblanche NK Adhikari A Douvdevani D Amichay Y Almog 2009 The effects of statin therapy on inflammatory cytokines in patients with bacterial infections: a randomized double-blind placebo controlled clinical trial Intensive Care Med 35 1255 1260 10.1007/s00134-009-1429-0 1:CAS:528:DC%2BD1MXnsVWmsL8%3D 19205663
12. T Mauri A Coppadoro G Bellani M Bombino N Patroniti G Peri A Mantovani A Pesenti 2008 Pentraxin 3 in acute respiratory distress syndrome: an early marker of severity Crit Care Med 36 2302 2308 10.1097/CCM.0b013e3181809aaf 1:CAS:528:DC%2BD1cXptFSmsLk%3D 18596636
13. T Sprong G Peri C Neeleman A Mantovani S Signorini JW van der Meer M van Deuren 2009 Pentraxin 3 and C-reactive protein in severe meningococcal disease Shock 31 28 32 10.1097/SHK.0b013e31817fd543 1:CAS:528:DC%2BD1MXhtVKhsbY%3D 18650775
14. R Latini AP Maggioni G Peri L Gonzini D Lucci P Mocarelli L Vago F Pasqualini S Signorini D Soldateschi L Tarli C Schweiger C Fresco R Cecere G Tognoni A Mantovani Lipid Assessment Trial Italian Network (LATIN) Investigators 2004 Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction Circulation 110 2349 2354 10.1161/01.CIR.0000145167.30987.2E 1:CAS:528:DC%2BD2cXosVSlsLY%3D 15477419 (Pubitemid 39407338)
15. K Inoue A Sugiyama PC Reid Y Ito K Miyauchi S Mukai M Sagara K Miyamoto H Satoh I Kohno T Kurata H Ota A Mantovani T Hamakubo H Daida T Kodama 2007 Establishment of a high sensitivity plasma assay for human pentraxin3 as a marker for unstable angina pectoris Arterioscler Thromb Vasc Biol 27 161 167 10.1161/01.ATV.0000252126.48375.d5 1:CAS:528:DC%2BD28XhtlSrsb%2FJ 17095712 (Pubitemid 46360394)
16. MI Yilmaz J Axelsson A Sonmez JJ Carrero M Saglam T Eyileten K Caglar A Kirkpantur T Celik Y Oguz A Vural M Yenicesu B Lindholm P Stenvinkel 2009 Effect of renin angiotensin system blockade on Pentraxin 3 levels in type-2 diabetic patients with proteinuria Clin J Am Soc Nephrol 4 535 541 10.2215/CJN.04330808 1:CAS:528:DC%2BD1MXktFKis74%3D 19211665
17. B Muller G Peri A Doni V Torri R Landmann B Bottazzi A Mantovani 2001 Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients Crit Care Med 29 1404 1407 10.1097/00003246-200107000-00017 1:CAS:528:DC%2BD3MXnt1Smt7o%3D 11445697
18. M Savioli M Cugno F Polli P Taccone G Bellani P Spanu A Pesenti G Iapichino L Gattinoni 2009 Tight glycemic control may favor fibrinolysis in patients with sepsis Crit Care Med 37 424 431 10.1097/CCM.0b013e31819542da 1:CAS:528:DC%2BD1MXjs1Kntbk%3D 19114908
19. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference 1992 Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis Crit Care Med 20 864 874
20. G van den Berghe P Wouters F Weekers C Verwaest F Bruyninckx M Schetz D Vlasselaers P Ferdinande P Lauwers R Bouillon 2001 Intensive insulin therapy in the critically ill patients N Engl J Med 345 1359 1367 10.1056/NEJMoa011300 11794168
21. L Ohno-Machado FS Resnic ME Matheny 2006 Prognosis in critical care Annu Rev Biomed Eng 8 567 599 10.1146/annurev.bioeng.8.061505.095842 1:CAS:528:DC%2BD28XptlKisL8%3D 16834567 (Pubitemid 44321385)
22. JL Vincent 2006 Organ dysfunction in patients with severe sepsis Surg Infect (Larchmt) 7 S2 S69 S72
23. T Mauri S Pivi LM Bigatello 2008 Prolonged mechanical ventilation after critical illness Minerva Anestesiol 74 297 301 1:STN:280:DC%2BD1czjvFSitA%3D%3D 18500202
24. LB Ware MA Matthay 2000 The acute respiratory distress syndrome N Eng J Med 342 1334 1349 10.1056/NEJM200005043421806 1:STN:280:DC%2BD3c3jvFGhsw%3D%3D (Pubitemid 30408719)
25. LB Ware MA Matthay PE Parsons BT Thompson JL Januzzi MD Eisner National Heart, Lung and Blood Institute Acute Respiratory Distress Syndrome Clinical Trials Network 2007 Pathogenic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome Crit Care Med 35 1821 1828 10.1097/01.CCM.0000221922.08878.49 17667242 (Pubitemid 47220354)
26. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL (2008) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 34:17-60
27. Erratum in (2008) Intensive Care Med 34:783-785
28. PC Reading S Bozza B Gilbertson M Tate S Moretti ER Job EC Crouch AG Brooks LE Brown B Bottazzi L Romani A Mantovani 2008 Antiviral activity of the long chain pentraxin PTX3 against influenza viruses J Immunol 180 3391 3398 1:CAS:528:DC%2BD1cXit1Oktrs%3D 18292565
29. L Deban H Jarva MJ Lehtinen B Bottazzi A Bastone A Doni TS Jokiranta A Mantovani S Meri 2008 Binding of the long pentraxin PTX3 to factor H: interacting domains and function in the regulation of complement activation J Immunol 181 8433 8440 1:CAS:528:DC%2BD1cXhsVCktr7E 19050261
30. AC Soares DG Souza V Pinho AT Vieira JR Nicoli FQ Cunha A Mantovani LF Reis AA Dias MM Teixeira 2008 Dual function of the long pentraxin PTX3 in resistance against pulmonary infection with Klebsiella pneumoniae in transgenic mice Microbes Infect 8 1321 1329 10.1016/j.micinf.2005.12.017
31. S Jaillon G Peri Y Delneste I Frémaux A Doni F Moalli C Garlanda L Romani H Gascan S Bellocchio S Bozza MA Cassatella P Jeannin A Mantovani 2007 The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps J Exp Med 204 793 804 10.1084/jem.20061301 1:CAS:528:DC%2BD2sXksFSqur0%3D 17389238 (Pubitemid 46631609)
32. R Gaziano S Bozza S Bellocchio K Perruccio C Montagnoli L Pitzurra G Salvatori R De Santis P Carminati A Mantovani L Romani 2004 Anti-Aspergillus fumigatus efficacy of pentraxin 3 alone and in combination with antifungals Antimicrob Agents Chemoter 48 4414 4421 10.1128/AAC.48.11.4414-4421.2004 1:CAS:528:DC%2BD2cXpvVyktrY%3D (Pubitemid 39434905)
33. M Salio S Chimenti N De Angelis F Molla V Maina M Nebuloni F Pasqualini R Latini C Garlanda A Mantovani 2008 Cardioprotective function of the long pentraxin PTX3 in acute myocardial infarction Circulation 117 1055 1064 10.1161/CIRCULATIONAHA.107.749234 1:CAS:528:DC%2BD1cXhvVyltbc%3D 18268142
34. PE Marik M Raghavan 2004 Stress-hyperglycemia, insulin and immunomodulation in sepsis Intensive Care Med 30 748 756 10.1007/s00134-004- 2167-y 14991101 (Pubitemid 38639464)
35. X He B Han M Liu 2007 Long pentraxin 3 in pulmonary infection and acute lung injury Am J Physiol Lung Cell Mol Physiol 292 L1039 L1049 10.1152/ajplung.00490.2006 1:CAS:528:DC%2BD2sXls1yhsr0%3D 17277044 (Pubitemid 47084848)
36. DG Souza FA Amaral CT Fagundes FM Coelho RM Arantes LP Sousa MM Matzuk C Garlanda A Mantovani AA Dias MM Teixeira 2009 The long pentraxin PTX3 is crucial for tissue inflammation after intestinal ischemia and reperfusion in mice Am J Pathol 174 1309 1318 10.2353/ajpath.2009.080240 1:CAS:528:DC%2BD1MXksVOktL4%3D 19286566
37. D Okutani B Han M Mura TK Waddell S Keshavjee M Liu 2007 High-volume ventilation induces pentraxin 3 expression in multiple acute lung injury models in rats Am J Physiol Lung Cell Mol Physiol 292 L144 L153 10.1152/ajplung.00002. 2006 1:CAS:528:DC%2BD2sXisFGjtrg%3D 16936248 (Pubitemid 46110451)
38. B Han M Mura CF Andrade D Okutani M Lodyga CC dos Santos S Keshavjee M Matthay M Liu 2005 TNFalpha-induced long pentraxin PTX3 expression in human lung epithelial cells via JNK J Immunol 175 8303 8311 1:CAS:528:DC%2BD2MXht12jt7rO 16339571
39. WR Parrish M Gallowitsch-Puerta CJ Czura KJ Tracey 2008 Experimental therapeutic strategies for severe sepsis Ann N Y Acad Sci 1144 210 236 10.1196/annals.1418.011 1:CAS:528:DC%2BD1MXhtVajt7o%3D 19076379
40. F Polli M Savioli M Cugno P Taccone G Bellani P Spanu A Pesenti G Iapichino L Gattinoni 2009 Effects of recombinant human activated protein C on the fibrinolytic system of patients undergoing conventional or tight glycemic control Minerva Anestesiol 75 1 10